Komori
ASKA Pharmaceutical Holdings (4886) · InitiativeAdvanced

Developing and Utilizing Human Resources Through a New Personnel System and Planned Training

First written in FY2022. 5 of 6 entries say "Advanced", first in FY2023. Latest entry: 2026-10-01.

6entries
5years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2022AdvancedFY2023 – 2026-10-012022: 120222023: 120232024: 120242025: 020252026: 32026
Same theme, other companies
Building a foundation for capability development through reforms to talent definitions and evaluation systemsA theme 178 companies write about · 0 as a headwind · 183 as a tailwind

102 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 178 companies compared. The sentences above are computed from all 178.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「主要な連結子会社である、あすか製薬株式会社では、2026年度からスタートした中期経営計画に定める成長戦略を実現するため、人的資本の最大化を目的とした新人事制度を同年4月より導入しています。」

    新人事制度・教育研修の取り組みについて、2026年4月から等級×Stage制や業績・タレントモデル評価を含む新人事制度を導入した。
  2. FY2024AdvancedAnnual report

    「2024年度には、グローバル化を牽引する人材の早期育成を目的とした、グローバル人材育成プログラム「GRAPE Program」を開始しました。」

    APPLE Programに続き、2024年度からグローバル人材育成プログラム「GRAPE Program」を開始している。
  3. FY2023AdvancedAnnual report

    「なお、2023年度より、当社グループの未来を担う次世代の経営リーダーを育成するため、年度を通して実施する選抜研修プログラム「APPLE Program」を開始しました。」

    新人事制度・教育研修の施策として、2023年度から次世代経営リーダー向け選抜研修プログラムを開始した。
  4. FY2022First statedAnnual report

    「We will develop an organizational structure capable of accommodating diverse career aspirations through a new personnel system, while expanding capabilities through planned education and training.」

    A new personnel system supporting diverse career aspirations and planned education and training are identified as human resources initiatives.
Moved together

"Establishment of an ESG Committee and Identification of 17 Material Issues" moved the same way as this thread, in the same document, in 3 of its 6 moves.

333333★123456
  1. ★This thread
  2. 1Establishment of an ESG Committee and Identification of 17 Material Issues3×
  3. 2CO2 Emissions Reduction and Energy-Saving Targets3×
  4. 3Partnerships with Other Companies, Including Domestic and Overseas M&A3×
  5. 4Development and Launch of a Hair Hormone Measurement Kit3×
  6. 5Reviewing the Rationale for Cross-Shareholdings and Selling Them3×
  7. 6Launch of the Dysmenorrhea Treatment DroEthi3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
ASKA Pharmaceutical Holdings's next results are scheduled for 2026-11-04. Read the earnings preview It last moved in the Governance of 2026-10-01: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.